The global veterinary orthopedic implants market size was USD 383.76 billion in 2023, estimated at USD 409.09 billion in 2024 and is anticipated to reach around USD 770.32 billion by 2034, expanding at a CAGR of 6.53% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Veterinary Orthopedic Implants Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Veterinary Orthopedic Implants Market
5.1. Covid-19: Veterinary Orthopedic Implants Industry Impact
5.2. Veterinary Orthopedic Implants Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Veterinary Orthopedic Implants Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Veterinary Orthopedic Implants Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Veterinary Orthopedic Implants Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increased number of companion animals
6.1.1.2. Rising expenditure on pet healthcare
6.1.2. Market Restraints
6.1.2.1. High Cost of advanced treatments
6.1.3. Market Opportunities
6.1.3.1. Growing research and development expenditure
6.1.3.2. Technological advancements
Chapter 7. Global Veterinary Orthopedic Implants Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Veterinary Orthopedic Implants Market Revenue by Market Players
7.1.1.2. Veterinary Orthopedic Implants Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Veterinary Orthopedic Implants Market, By Product
8.1. Veterinary Orthopedic Implants Market, by Product, 2024-2034
8.1.1. Screws
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Pins & Wires
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Plates
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Jigs
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Veterinary Orthopedic Implants Market, By End User
9.1. Veterinary Orthopedic Implants Market, by End User, 2024-2034
9.1.1. Veterinary Clinics
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Veterinary Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Veterinary Orthopedic Implants Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product(2021-2034)
10.1.2. Market Revenue Forecast by End User(2021-2034)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2034)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2034)
10.2. Europe
10.2.1. Market Revenue Forecast by Product (2021-2034)
10.2.2. Market Revenue Forecast by End User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2034)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2034)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product (2021-2034)
10.3.2. Market Revenue Forecast by End User (2021-2034)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2034)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2034)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product (2021-2034)
10.4.2. Market Revenue Forecast by End User (2021-2034)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2034)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2034)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product (2021-2034)
10.5.2. Market Revenue Forecast by End User (2021-2034)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2034)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2034)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2034)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2034)
Chapter 11. Company Profiles
11.1. DePuy Synthes Vet
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Distribution Channel
11.1.3. Revenue, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. KYON Pharma, Inc.
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Distribution Channel
11.2.3. Revenue, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. MWI Veterinary Supply Co.
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Distribution Channel
11.3.3. Revenue, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. Vet Implants
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Distribution Channel
11.4.3. Revenue, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. B. Braun Melsungen AG
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Distribution Channel
11.5.3. Revenue, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Everost, Inc.
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Distribution Channel
11.6.3. Revenue, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. IMEX Veterinary, Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Distribution Channel
11.7.3. Revenue, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. BioMedtrix, LLC
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Distribution Channel
11.8.3. Revenue, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Securos Surgical
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Distribution Channel
11.9.3. Revenue, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Vet Implants
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Distribution Channel
11.10.3. Revenue, Price, and Gross Margin
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client